iPLesp - Institut Pierre Louis d'épidémiologie et de santé publique

Type: Research entity evaluation report

Evaluation campaign: 2023-2024 (group D) - Published on: 05/04/2024

Institution(s) concerned: Sorbonne Université , Institut national de la santé et de la recherche médicale - INSERM

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE7 - Prévention, diagnostic et traitement des maladies humaines (médecine préventive et pronostique, santé publique et épidémiologie, santé environnementale, médecine du travail, soins de santé, y compris soins pour la population vieillissante, technolo

ERC panel(s): LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics

Name of unit teams: SUMO ; CLEPIVIR ; THERAVIR ; NEMESIS ; PEPITES ; ERES ; 1.Improving surveillance, participatory surveillance methods, and developing models for infectious diseasesprediction and intervention evaluation (SUMO team) ; 2.Conducting large-scale clinical cohorts on HIV, hepatitis, HIV-hepatitis co-infection to evaluate antiviraltreatments' risks/benefits (CLEPIVIR team). ; 3.Optimizing HIV antiviral efficacy, studying HIV-cancer interactions, evaluating HIV transmission prevention(THERAVIR team) ; 4.Studying impact of urban environments, mobility, transport on health (NEMESIS team) ; 5.Evaluating drug/multimodal management in inflammatory diseases or elderly, using large medico-administrative databases (PEPITES team) ; 6.Identifying social health determinants, impact of social inequalities, particularly on mental health, addictions(ERES team)

Keywords: Inégalités sociales de santé ; santé des migrants ; pays du sud ; maladies inflammatoires